Filing Details
- Accession Number:
- 0000899243-22-004607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 16:30:41
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 16:30:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1785173 | 89Bio Inc. | ETNB | Pharmaceutical Preparations (2834) | 831114349 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792064 | Ram Waisbourd | C/O 89Bio, Inc. 142 Sansome Street, 2Nd Floor San Francisco CA 94104 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-01 | 4,000 | $1.93 | 4,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-01 | 3,000 | $1.93 | 7,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-01 | 7,000 | $5.70 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-01 | 4,000 | $0.00 | 4,000 | $1.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-01 | 3,000 | $0.00 | 3,000 | $1.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,203 | 2028-11-09 | No | 4 | M | Direct | |
| 3,106 | 2029-10-01 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $5.43 to $5.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
- This option represents a right to purchase a total of 20,106 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
Billionaire Hedge Funds
